All Journals > The Journal of Infectious Diseases > 15 July 2005 > Type I IFN Production Loss in Primary HIV Infection

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 July 2005

Volume 192, Number 2
The Journal of Infectious Diseases 2005;192:303–310
0022-1899/2005/19202-0014$15.00
DOI: 10.1086/430931
MAJOR ARTICLE

Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV‐1 Infection

Isabelle Kamga,1

Sandrine Kahi,1,a

Leyla Develioglu,1

Miriam Lichtner,1,a

Concepción Marañón,1

Christiane Deveau,3

Laurence Meyer,3

Cécile Goujard,4

Pierre Lebon,2

Martine Sinet,5 and

Anne Hosmalin1

1Institut Cochin, Département d’Immunologie, INSERM U567, Centre National de la Recherche Scientifique, UMR 8104, IFR 116, Université Paris V René Descartes, and 2Faculté de Médecine, IFR 116, Université René Descartes, Paris, and 3INSERM U569, Cohorte PRIMO–Agence Nationale de Recherche contre le Sida, 4Service de Médecine Interne, Hôpital de Bicêtre, and 5Unité INSERM E0109, Immunité antivirale systémique et cérébrale, Kremlin‐Bicêtre, France

Background.Successful immunological control of human immunodeficiency virus (HIV) infection is achieved only in rare individuals. Plasmacytoid dendritic cells (DCs) are mostly responsible for the production of strong antiviral factors—that is, type I interferons (IFNs)—in response to viruses. Their natural IFN production is impaired in chronic HIV infection, in correlation with viral load and disease progression, but it has not been tested during the critical stage of primary infection, when a balance is set between host immune responses and viral replication.

Methods.We longitudinally studied 26 patients during the primary stage of HIV infection. Fifteen patients received highly active antiretroviral therapy (HAART) for 12 months.

Results.At the time of inclusion into the cohort, median type I IFN production in response to herpes simplex virus type 1 stimulation was dramatically impaired in peripheral blood mononuclear cells (PBMCs) from HIV‐infected patients, compared with that in PBMCs from 31 uninfected donors (180 vs. 800 IU/mL; ). Median circulating plasmacytoid DC counts were also significantly decreased (7300 vs. 13,500 cells/mL; ). Twelve months later, IFN production returned to normal, and the data suggest that HAART may help in the recovery of IFN production by plasmacytoid DCs.

Conclusions.These data underline the potential for early antiretroviral treatment and IFN‐α treatment to enhance viral control in a larger proportion of patients during the critical stage of primary infection.

Received 2 December 2004; accepted 10 February 2005; electronically published 15 June 2005.

Reprints or correspondence: Dr. Anne Hosmalin, Immunology Dept., Institut Cochin, INSERM U 567, 27 rue du Fg St‐Jacques, Bât G. Roussy, 8è étage, 75014 Paris, France ().

Cited by

Shamman Sewram, Ravesh Singh, Emil Kormuth, Lise Werner, Koleka Mlisana, S. S. Abdool Karim, Thumbi Ndung’u, and the CAPRISA Acute Infection Study Team. (2009) Human TRIM5α Expression Levels and Reduced Susceptibility to HIV‐1 Infection. The Journal of Infectious Diseases 199:11, 1657-1663
Online publication date: 1-Jun-2009.
Julie Fontaine, François Coutlée, Cécile Tremblay, Jean‐Pierre Routy, Johanne Poudrier, and Michel Roger, for the Montreal Primary HIV Infection and Long‐Term Nonprogressor Study Groups. (2009) HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease. The Journal of Infectious Diseases 199:7, 1007-1018
Online publication date: 1-Apr-2009.
B. Malleret, B. Maneglier, I. Karlsson, P. Lebon, M. Nascimbeni, L. Perie, P. Brochard, B. Delache, J. Calvo, T. Andrieu, O. Spreux-Varoquaux, A. Hosmalin, R. Le Grand, B. Vaslin. (2009) Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112:12, 4598-4608
Online publication date: 1-Jan-2009.
CrossRef
Benoît Malleret, Ingrid Karlsson, Benjamin Manéglier, Patricia Brochard, Benoît Delache, Thibault Andrieu, Michaela Muller-Trutwin, Tim Beaumont, Joseph M. McCune, Jacques Banchereau, Roger Le Grand, Bruno Vaslin. (2008) Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques. Immunology 124:2, 223-233
Online publication date: 1-Jul-2008.
CrossRef
Alessandra Sottini, Claudia Ghidini, Federico Serana, Marco Chiarini, Monica Valotti, Raffaele Badolato, Annalisa Radeghieri, Luigi Caimi, Luisa Imberti. (2008) Decreased Type I Interferon Receptor-Soluble Isoform in Antiretroviral-Treated HIV-Positive Children. Journal of Interferon & Cytokine Research 28:3, 181-189
Online publication date: 1-Apr-2008.
CrossRef
Charles K. Nfon, Geoffrey S. Ferman, Felix N. Toka, Douglas A. Gregg, William T. Golde. (2008) Interferon-α Production by Swine Dendritic Cells Is Inhibited During Acute Infection with Foot-and-Mouth Disease Virus. Viral Immunology 21:1, 68-77
Online publication date: 1-Apr-2008.
CrossRef
Persephone Borrow, Nina Bhardwaj. (2008) Innate immune responses in primary HIV-1 infection. Current Opinion in HIV and AIDS 3:1, 36-44
Online publication date: 1-Feb-2008.
CrossRef
Seema Desai, Aida Chaparro, Huanliang Liu, Patrick Haslett, Kristopher Arheart, Gwendolyn Scott, Rajendra Pahwa, Savita Pahwa. (2007) Impaired CCR7 Expression on Plasmacytoid Dendritic Cells of HIV-Infected Children and Adolescents With Immunologic and Virologic Failure. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:5, 501-507
Online publication date: 1-Sep-2007.
CrossRef
Masaaki Shiina, Koju Kobayashi, Tomoo Kobayashi, Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. (2006) Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24–positive chronic hepatitis C patients. Journal of Gastroenterology 41:8, 758-764
Online publication date: 19-Oct-2006.
CrossRef
M. Lichtner, R. Rossi, F. Mengoni, S. Vignoli, B. Colacchia, A. P. Massetti, I. Kamga, A. Hosmalin, V. Vullo, C. M. Mastroianni. (2006) Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clinical and Experimental Immunology 143:2, 329-337
Online publication date: 1-Mar-2006.
CrossRef
George M Bahr. (2005) Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses. Expert Review of Clinical Immunology 1:4, 529-547
Online publication date: 1-Dec-2005.
CrossRef
Michaela Muller-Trutwin, Anne Hosmalin. (2005) Role for plasmacytoid dendritic cells in anti-HIV innate immunity. Immunology and Cell Biology 83:5, 578-585
Online publication date: 1-Nov-2005.
CrossRef
  • Presented in part: 12th International Congress of Immunology and 4th Annual Conference of the Federation of Clinical Immunology Societies, Montreal, Canada, 22 July 2004.

    Financial support: Agence Nationale de Recherche contre le Sida; Ensemble contre le SIDA (Sidaction); Institut National de la Recherche Médicale (INSERM).

  • Present affiliations: INSERM SC‐10, Hôpital Paul Brousse, Villejuif, France (S.K.); Dipartimento Malattie Infettive e Tropicali, Policlinico Umberto 1‐Universita di Roma la Sapienza, Rome, Italy (M.L.).

Close Popup